Scarica l'app Stockscreener
12.42
3.20%
-0.41
Pre-mercato:
12.36
-0.06
-0.48%
Precedente Chiudi:
$12.83
Aprire:
$12.45
Volume 24 ore:
1.95M
Relative Volume:
0.93
Capitalizzazione di mercato:
$3.10B
Reddito:
$496.43M
Utile/perdita netta:
$71.35M
Rapporto P/E:
43.59
EPS:
0.2849
Flusso di cassa netto:
$151.57M
1 W Prestazione:
-4.83%
1M Prestazione:
-5.77%
6M Prestazione:
-35.45%
1 anno Prestazione:
-19.72%
Intervallo 1D:
$12.16
$12.79
Intervallo di 1 settimana:
$12.16
$13.16
Portata 52W:
$11.02
$19.98
Cellebrite Di Ltd Stock (CLBT) Company Profile
Nome
Cellebrite Di Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Compare CLBT vs MSFT, ORCL, PLTR, CRWD, FTNT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLBT
Cellebrite Di Ltd
|
12.42 | 3.20B | 496.43M | 71.35M | 151.57M | 0.2849 |
MSFT
Microsoft Corp
|
367.34 | 2.82T | 318.27B | 125.22B | 72.92B | 16.79 |
ORCL
Oracle Corp
|
175.07 | 530.03B | 64.08B | 16.40B | -24.74B | 5.5698 |
PLTR
Palantir Technologies Inc
|
119.50 | 307.98B | 5.22B | 2.29B | 2.69B | 0.8876 |
CRWD
Crowdstrike Holdings Inc
|
675.44 | 174.34B | 5.09B | -24.89M | 1.43B | -0.1885 |
FTNT
Fortinet Inc
|
145.39 | 106.04B | 7.11B | 1.95B | 2.44B | 2.5883 |
Cellebrite Di Ltd Stock (CLBT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-03-28 | Reiterato | Needham | Buy |
| 2024-03-13 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-02-16 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-07-19 | Iniziato | Craig Hallum | Buy |
| 2022-08-12 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-08-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-02-24 | Iniziato | JP Morgan | Overweight |
| 2022-02-11 | Iniziato | Deutsche Bank | Buy |
| 2021-12-02 | Iniziato | BofA Securities | Buy |
| 2021-10-21 | Iniziato | Citigroup | Buy |
Mostra tutto
Cellebrite Di Ltd Borsa (CLBT) Ultime notizie
Cellebrite DI strategy in focus, Nasdaq-listed shares under analyst scrutiny - AD HOC NEWS
Cellebrite DI (CLBT) Stock Could Be 23% Undervalued After Genesis AI Launch - simplywall.st
Cellebrite (CLBT)’s Total Addressable Market Is Large, Growing, And Likely Understated, According To DA Davidson - Yahoo Finance
Is Cellebrite DI Ltd. (CLBT) A Good Stock To Buy Now? - Insider Monkey
10 Stocks Under $20 That Will Explode - Insider Monkey
Cellebrite DI Ltd (CLBT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cellebrite DI Ltd (CLBT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cellebrite DI Ltd (CLBT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cellebrite DI Ltd (CLBT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cellebrite DI Ltd (CLBT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cellebrite DI Ltd (CLBT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cellebrite DI Ltd (CLBT) Institutional Confidence - TradingKey
Cellebrite DI Ltd (CLBT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cellebrite DI Ltd (CLBT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Will Cellebrite’s AI‑Powered Genesis Platform Redefine Cellebrite DI's (CLBT) Narrative on Evidence Analysis? - simplywall.st
Cellebrite DI Ltd Faces Market Dynamics as Stock Volatility Surges - timothysykes.com
Cellebrite: Stronger Fundamentals Support A Buy Rating (NASDAQ:CLBT) - Seeking Alpha
Cellebrite Genesis: AI-Powered Investigative Solutions - SecurityInformed.com
Cellebrite Genesis: AI investigative tool launch - SourceSecurity.com
Cellebrite Launches the New Age of Investigations with Genesis, Now Generally Available - Macau Business
[PRNewswire] Cellebrite Launches the New Age of Investigations - Yonhap News Agency
Cellebrite DI Ltd. (CLBT) Latest Stock News & Headlines - Yahoo Finance
CLBT: AI-powered tools now deliver rapid, multi-source investigative insights, transforming case workflows - TradingView
Cellebrite launches AI investigation tool Genesis By Investing.com - Investing.com
Cellebrite Di Ltd. Announces General Availability of Genesis - marketscreener.com
Cellebrite DI Ltd stock (IL0011384071): Focus on digital intelligence growth after recent earnings - AD HOC NEWS
Cellebrite Announces Upcoming Investor Events on June 10, 2026 - PR Newswire
Cellebrite receives FedRAMP High Authorization for cloud platform - Investing.com
[PRNewswire] Cellebrite Announces Upcoming Investor Events - Yonhap News Agency
3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market - The Motley Fool
TD Cowen reiterates Buy rating on Cellebrite stock at $23 target By Investing.com - Investing.com South Africa
TD Cowen reiterates Buy rating on Cellebrite stock at $23 target - Investing.com Australia
Tracking How the Cellebrite (CLBT) Investment Narrative Is Evolving Without New Analyst Targets - Yahoo Finance
CLBT News | CELLEBRITE DI LTD (NASDAQ:CLBT) - ChartMill
Cellebrite DI Ltd. Hits Day High with 11.59% Surge in Stock Price - MarketsMojo
Cellebrite DI Ltd. Hits Day High with 7.74% Surge in Stock Price - Markets Mojo
Cellebrite DI (CLBT) Is Up 20.4% After FedRAMP Win And AI Launch MomentumHas The Bull Case Changed? - simplywall.st
126,264-share resale planned for CLBT (NASDAQ: CLBT) via Morgan Stanley - Stock Titan
Why is Cellebrite DI stock rallying 6% today? By Investing.com - Investing.com South Africa
Is It Time To Reassess Cellebrite DI (CLBT) After The Recent Share Price Rebound? - simplywall.st
Why is Cellebrite stock surging 8% today? By Investing.com - Investing.com Australia
CLBT: Upcoming Virtual Meeting Announced for June 4 - GuruFocus
A Look At Cellebrite DI (NasdaqGS:CLBT) Valuation As AI And FedRAMP Cloud Momentum Build - simplywall.st
Cellebrite DI Ltd. (CLBTW) Stock Price, News, Quote & History - Yahoo Finance
Cellebrite DI Eyes AI, Cloud and FedRAMP as Digital Investigations Demand Grows - MarketBeat
TD Cowen Maintains Cellebrite(CLBT.US) With Buy Rating, Maintains Target Price $23 - Moomoo
Cellebrite Di Ltd Azioni (CLBT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.29%
1.99%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):